Found 35 matching trials
Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis PHASE3 The trial is performed to assess efficacy and safety of the Grass Pollen Al...
Show More Location
Allergopharma GmbH & Co. KG
Learn More & Join Trial
Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutaneous Allergen Administration PHASE2 Evaluation of patch as specific immunotherapy in allergic patients...
Location
Multiple Locations
Learn More & Join Trial
Vitamin D and Grass Pollen Specific Immunotherapy PHASE2 Allergen-specific immunotherapy is the only causal therapy of Immunoglobuli...
Show More Location
Charité Universitätsmedizin Berlin, Allergy-Centre-Charité, CCM
Learn More & Join Trial
A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy PHASE2 Allergen specific immunotherapy (SIT) is the only causative treatment of Ig...
Show More Location
Clinic for Dermatology University Hospital of Zurich
Learn More & Join Trial
Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen PHASE2 Grass MATA (modified pollen allergen tyrosine adsorbate) has been developed...
Show More Location
College Park Family Care Center Multi-Specialty Clinical Research
Learn More & Join Trial
Regulatory Lymphocytes in Patients Treated With Specific Immunotherapy PHASE4 The purpose of this study is to determine whether specific subcutaneous imm...
Show More Location
Department of Pneumonology and Allergy, Medical University of Lodz
Learn More & Join Trial
Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen PHASE2 Allergen-specific immunotherapy (SIT), the administration of gradually incr...
Show More Location
Allied Research International Inc.
Learn More & Join Trial
Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma PHASE3 Efficacy and Safety from a high-dosed subcutaneous recombinant preparation...
Location
Allergopharma GmbH & Co. KG
Learn More & Join Trial
Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture PHASE3 The trial is performed to asses efficacy and safety of a sublingual extract...
Show More Location
Allergopharma GmbH & Co. KG
Learn More & Join Trial
Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing PHASE1 The purpose of this study is to evaluate the residual allergenicity of Gras...
Show More Location
Allergy Associates Research Center
Learn More & Join Trial